Angiotensin Converting Enzyme Inhibitor

Product Description

Angiotensin Converting Enzyme Inhibitor
Catalog number: B2010519
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: 1101.26 g/mol
Supplied as: Powder
Applications: molecular tool for various ACE-related research studies
Storage: −20°C
Keywords: ACE Inhibitor
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-
induced angioedema: A review of the literature. J Clin Hypertens (Greenwich).
2017 Dec;19(12):1377-1382.

2: Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP
evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1
Suppl):169S-173S.

3: Bankston J, House DT. Angiotensin-Converting_Enzyme_Inhibitor Angioedema. Adv
Emerg Nurs J. 2020 Apr/Jun;42(2):103-107.

4: De Bono JA, Conte SM, Newcomb AE. Effects of Preoperative Angiotensin-
Converting Enzyme_Inhibitor Therapy on Postoperative Renal Function in Cardiac
Surgery. Heart Lung Circ. 2020 Nov;29(11):1656-1667.

5: Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B. The
Effect of Prior Angiotensin-Converting Enzyme_Inhibitor and Angiotensin Receptor
Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and
Outcome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 Jun
1;72(11):e901-e913.

6: Laurent S. Antihypertensive drugs. Pharmacol Res. 2017 Oct;124:116-125.

7: Sobotková M. Angiotensin-converting_enzyme_inhibitor-induced angioedema:
epidemiology, pathogenesis and management. Vnitr Lek. 2018 Fall;64(10):928-933.
English.

8: de Feria A, Ortega-Legaspi JM. Angiotensin-converting_Enzyme
Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice
or Keep Gathering Data? Clin Infect Dis. 2020 Dec 3;71(9):2457-2458.

9: Sommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus Disease 2019
(COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor
Blockers Have a Biphasic Effect? J Am Heart Assoc. 2020 Apr 7;9(7):e016509.
10: Izzo JL Jr, Weir MR. Angiotensin-converting enzyme inhibitors. J Clin
Hypertens (Greenwich). 2011 Sep;13(9):667-75.

Products Related to Angiotensin Converting Enzyme Inhibitor and other chemicals : SARS-CoV-2